Abstract
Ataxia telangiectasia (A-T) is a rare autosomal recessive disorder caused by biallelic mutations in the Ataxia Telangiectasia-mutated gene. A-T shows a complex phenotype ranging from early-onset progressive neurodegeneration to immunodeficiencies, high incidence of infections, and tumors. Unfortunately, no therapy is up to now available for treating this condition. Recently, the short term treatment of ataxia-telangiectasia patients with glucocorticoids was shown to improve their neurological symptoms and possibly reverse cerebellar atrophy. Thus, corticosteroids represent an attractive approach for the treatment of this neurodegenerative disease. However, the molecular mechanism involved in glucocorticoid action in A-T is yet unknown. The aim of our work is to construct cDNA libraries containing those genes which are transactivated by the glucocorticoid analogue, dexamethasone, in A-T human cells. For this purpose, suppression subtractive hybridization has been performed on ATM-null lymphoblastoid cell transcriptome extracted following drug administration. Annotation of whole genes contained in the libraries has been obtained by coupling subtractive hybridization with microarray analysis. Positive transcripts have been validated by quantitative PCR. Through in silico analyses, identified genes have been classified on the basis of the pathway in which they are involved, being able to address signaling required for dexamethasone action. Most of the induced transcripts are involved in metabolic processes and regulation of cellular processes. Our results can help to unravel the mechanism of glucocorticoid action in the reversion of A-T phenotype. Moreover, the induction of a specific region of the ATM transcript has been identified as putative biomarker predictive of dexamethasone efficacy on ataxic patients.
Similar content being viewed by others
Abbreviations
- A-T:
-
Ataxia telangiectasia
- GC:
-
Glucocorticoid
- dexa:
-
Dexamethasone
- SSH:
-
Suppression subtractive hybridization
- GRE:
-
Glucocorticoid responsive elements
- LCLs:
-
Lymphoblastoid cell lines
References
Savitsky K, Bar-Shira A, Gilad S et al (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749–1753
Abraham RT (2004) PI 3-kinase related kinases: ‘big’ players in stress-induced signaling pathways. DNA Repair (Amst) 3:883–887
Shiloh Y, Ziv Y (2012) The ATM protein: the importance of being active. J Cell Biol 198:273–275
Biton S, Barzilai A, Shiloh Y (2008) The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle. DNA Repair (Amst) 7:1028–1038
Chun HH, Gatti RA (2004) Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 3:1187–1196
Lavin MF (2008) Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9:759–769
Gilad S, Chessa L, Khosravi R et al (1998) Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet 62:551–561
Broccoletti T, Del GE, Amorosi S et al (2008) Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients. Eur J Neurol 15:223–228
Broccoletti T, Del GE, Cirillo E et al (2011) Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia. Eur J Neurol 18:564–570
Buoni S, Zannolli R, Sorrentino L et al (2006) Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia. Arch Neurol 63:1479–1482
Zannolli R, Sabrina B, Betti G et al (2012) A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia. Mov Disord 27:1312–1316
Gatti RA, Perlman S (2009) A proposed bailout for A-T patients? Eur J Neurol 16:653–655
Biagiotti S, Paoletti MF, Fraternale A et al (2011) Drug delivery by red blood cells. IUBMB Life 63:621–631
Bossa F, Latiano A, Rossi L et al (2008) Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study. Am J Gastroenterol 103:2509–2516
Castro M, Rossi L, Papadatou B et al (2007) Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease. J Pediatr Gastroenterol Nutr 44:423–426
Pierige F, Serafini S, Rossi L et al (2008) Cell-based drug delivery. Adv Drug Deliv Rev 60:286–295
Reeves EK, Rayavarapu S, Damsker JM et al (2012) Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases. Endocr Metab Immune Disord Drug Targets 12:95–103
Barzilai A, Biton S, Shiloh Y (2008) The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair (Amst) 7:1010–1027
Barzilai A (2010) DNA damage, neuronal and glial cell death and neurodegeneration. Apoptosis 15:1371–1381
Ditch S, Paull TT (2012) The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem Sci 37:15–22
Russo I, Cosentino C, Del GE et al (2009) In ataxia-telangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity. Eur J Neurol 16:755–759
Giardino G, Fusco A, Romano R et al (2013) Betamethasone therapy in ataxia telangiectasia: unraveling the rationale of this serendipitous observation on the basis of the pathogenesis. Eur J Neurol 20:740–747
Li J, Chen J, Ricupero CL et al (2012) Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 18:783–790
Kadmiel M, Cidlowski JA (2013) Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci 34:518–530
Oakley RH, Cidlowski JA (2013) The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 132(5):1033–1044
Barnes PJ (2011) Glucocorticosteroids: current and future directions. Br J Pharmacol 163:29–43
Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids: new mechanisms for old drugs. N Engl J Med 353:1711–1723
Lit L, Sharp FR, Apperson M et al (2009) Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy. Pharmacogenomics J 9:411–418
Diatchenko L, Lau YF, Campbell AP et al (1996) Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93:6025–6030
Menotta M, Biagiotti S, Bianchi M et al (2012) Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity. J Biol Chem 287:41352–41363
Nishimura M, Koeda A, Suzuki E et al (2006) Effects of prototypical drug-metabolizing enzyme inducers on mRNA expression of housekeeping genes in primary cultures of human and rat hepatocytes. Biochem Biophys Res Commun 346:1033–1039
de Kok JB, Roelofs RW, Giesendorf BA et al (2005) Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85:154–159
Yakubov E, Dinerman P, Kuperstein F et al (2005) Improved representation of gene markers on microarray by PCR-Select subtracted cDNA targets. Brain Res Mol Brain Res 137:110–118
Harms C, Albrecht K, Harms U et al (2007) Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci 27:4562–4571
Barr CS, Dokas LA (1999) Glucocorticoids regulate the synthesis of HSP27 in rat brain slices. Brain Res 847:9–17
Prager EM, Johnson LR (2009) Stress at the synapse: signal transduction mechanisms of adrenal steroids at neuronal membranes. Sci Signal 2:re5
Chessa L, Leuzzi V, Plebani A et al (2014) Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia telangiectasia patients: results of a phase 2 trial. Orphanet J Rare Dis 9:5
Baschant U, Lane NE, Tuckermann J (2012) The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol 8:645–655
Datson NA, Morsink MC, Meijer OC et al (2008) Central corticosteroid actions: search for gene targets. Eur J Pharmacol 583:272–289
Morsink MC, Steenbergen PJ, Vos JB et al (2006) Acute activation of hippocampal glucocorticoid receptors results in different waves of gene expression throughout time. J Neuroendocrinol 18:239–252
Datson NA, van der Perk J, de Kloet ER et al (2001) Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci 14:675–689
Cosentino C, Grieco D, Costanzo V (2011) ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30:546–555
Costanzo V (2013) ATM dependent control of cellular metabolism. Ataxia Telangiectasia Worshop 2013, University of Birmingham, Birmingham, UK, 28th–31st July 2013
Saad MJ, Folli F, Araki E et al (1994) Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone. Mol Endocrinol 8:545–557
Halaby MJ, Hibma JC, He J et al (2008) ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells. Cell Signal 20:1555–1563
Prager EM, Johnson LR (2009) Stress at the synapse: signal transduction mechanisms of adrenal steroids at neuronal membranes. Sci Signal 2:re5
Ambrose M, Gatti RA (2013) Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 121:4036–4045
Ambrose M, Goldstine JV, Gatti RA (2007) Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum Mol Genet 16:2154–2164
Stern N, Hochman A, Zemach N et al (2002) Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J Biol Chem 277:602–608
Valentin-Vega YA, Maclean KH, Tait-Mulder J et al (2012) Mitochondrial dysfunction in ataxia-telangiectasia. Blood 119:1490–1500
Valentin-Vega YA, Kastan MB (2012) A new role for ATM: regulating mitochondrial function and mitophagy. Autophagy 8:840–841
Rachamim N, Latter H, Malinin N et al (1995) Dexamethasone enhances expression of mitochondrial oxidative phosphorylation genes in rat distal colon. Am J Physiol 269:C1305–C1310
Van Itallie CM (1992) Dexamethasone treatment increases mitochondrial RNA synthesis in a rat hepatoma cell line. Endocrinology 130:567–576
Weber K, Bruck P, Mikes Z et al (2002) Glucocorticoid hormone stimulates mitochondrial biogenesis specifically in skeletal muscle. Endocrinology 143:177–184
Morsink MC, Joels M, Sarabdjitsingh RA et al (2006) The dynamic pattern of glucocorticoid receptor-mediated transcriptional responses in neuronal PC12 cells. J Neurochem 99:1282–1298
Montecucco A, Biamonti G (2013) Pre-mRNA processing factors meet the DNA damage response. Front Genet 4:102
Acknowledgments
This work was partially supported by “Fondazione M. Vocale.” Sara Biagiotti hold a fellowship from Fondazione Cassa di Risparmio di Fano sponsorized by FANOATENEO and Associazione Nazionale A-T “Davide DeMarini.”
Author information
Authors and Affiliations
Corresponding authors
Additional information
Sara Biagiotti and Michele Menotta contribute equally to the work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Biagiotti, S., Menotta, M., Giacomini, E. et al. Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells. Mol Cell Biochem 392, 13–30 (2014). https://doi.org/10.1007/s11010-014-2013-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-014-2013-7